A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis

PHASE2CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Bacterial Vaginosis
Interventions
DRUG

SYM-1219

Oral

DRUG

Placebo

Oral

Trial Locations (16)

19114

Clinical Research of Philadelphia, LLC, Philadelphia

23502

Tidewater Physicians for Women, Virginia Beach

28562

Eastern Carolina Women's Center, New Bern

30075

Atlanta North Gynecology, P.C, Roswell

33161

Healthcare Clinical Data, Inc., North Miami

33759

Women's Medical Research Group, LLC, Clearwater

35294

University of Alabama at Birmingham, Birmingham

38305

The Jackson Clinic, PA, Jackson

48201

Wayne State University, Detroit

48604

Saginaw Valley Medical Research Group, LLC, Saginaw

77054

TMC Life Research, Inc., Houston

78229

Clinical Trials of Texas, Inc., San Antonio

92123

Women's Health Care Research Corp., San Diego

98104

University of Washington, Harborview Medical Center, Seattle

08648

Lawrence OB-GYN Clinical Research, LLC, Lawrenceville

08536

Scott Eder MD, Plainsboro

Sponsors
All Listed Sponsors
lead

Symbiomix Therapeutics

INDUSTRY